参考文献/References:
[1] Jennette JC,Falk RJ,Bacon PA,et al.2012 revised international chapel hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65(1):1-11.
[2] 张慧敏,孙腾,关婷,等.大动脉炎累及冠状动脉临床特点及预后分析[J].中国循环杂志,2012,27(5):349-352.
[3] Gudbrandsson B,Molberg O,Garen T,et al.Prevalence,incidence,and disease characteristics of takayasu arteritis by ethnic background:data from a large,population-based cohort resident in southern norway[J].Arthritis Care Res (Hoboken),2017,69(2):278-285.
[4] Kim H,Barra L.Ischemic complications in Takayasu’s arteritis:a meta-analysis[J].Semin Arthritis Rheum,2018,47(6):900- 906.
[5] Lei C,Huang Y,Yuan S,et al.Takayasu arteritis with coronary artery involvement:differences between pediatric and adult patients[J].Can J Cardiol,2020,36(4):535-542.
[6] Yang Y,Tian T,Yang K,et al.Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis[J].Int J Cardiol,2017,241:64-69.
[7] Wang X,Dang A,Lv N,et al.Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement[J].Semin Arthritis Rheum,2017,47(2):247-252.
[8] Armellin L,Sammel AM,Ng B,et al.Coronary artery stenting in acute coronary syndrome associated with giant cell arteritis[J].J Cardiol Cases,2017,16(3):77-81.
[9] Dagan A,Mahroum N,Segal G,et al.The association between giant cell arteritis and ischemic heart disease:a population based cross-sectional study[J].Isr Med Assoc J,2017,19(7):411-414.
[10] Udayakumar PD,Chandran AK,Crowson CS,et al.Cardiovascular risk and acute coronary syndrome in giant cell arteritis:a population-based retrospective cohort study[J].Arthritis Care Res (Hoboken),2015,67(3):396-402.
[11] Andrade J,Ali AA,Saw J,et al.Acute stent thrombosis in a patient with giant cell arteritis[J].Can J Cardiol,2008,24(4):e25-e26.
[12] Bozlu G,Karpuz D,Hallioglu O,et al.Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease[J].Cardiol Young,2018,28(6):832-836.
[13] Ishii M,Ueno T,Akagi T,et al.Guideline for catheter intervention in coronary artery lesion in kawasaki disease[J].Pediatr Int,2001,43(5):558-562.
[14] 徐源蔚,陈玉成.心脏磁共振在检测自身免疫性风湿疾病心脏受累中的应用进展[J].心血管病学进展,2019,40(5):676-679.
[15] Suda K,Iemura M,Nishiono H,et al.Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms:a single-institution experience[J].Circulation,2011,123(17):1836-1842.
[16] Akagi T.Catheter interventions for kawasaki disease:current concepts and future directions[J].Korean Circ J,2011,41(2):53-57.
[17] Kitamura S,Tsuda E.Significance of coronary revascularization for coronary-artery obstructive lesions due to kawasaki disease[J].Children (Basel),2019,6(2):16.
[18] Tsuda E,Kitamura S,Cooperative Study Group of J.National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan[J].Circulation,2004,110(11 suppl 1):II61-II66.
[19] Hernandez-Rodriguez J,Alba MA,Prieto-Gonzalez S,et al.Diagnosis and classification of polyarteritis nodosa[J].J Autoimmun,2014,48-49:84-89.
[20] Cassling RS,Lortz JB,Olson DR,et al.Fatal vasculitis (periarteritis nodosa) of the coronary arteries:Angiographic ambiguities and absence of aneurysms at autopsy[J].J Am Coll Cardiol,1985,6(3):707-714.
[21] Lewandowski M,Goracy J,Kossuth I,et al.Vasculitis or coronary atherosclerosis? Optical coherence tomography images in polyarteritis nodosa[J].Kardiol Pol,2018,76(4):813.
[22] Bayturan O,Tarhan S,Copkiran O,et al.Endovascular coil treatment of a coronary artery aneurysm related to polyarteritis nodosa[J].Anatol J Cardiol,2017,18(5):370-372.
[23] Moosig F,Bremer JP,Hellmich B,et al.A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss,EGPA):monocentric experiences in 150 patients[J].Ann Rheum Dis,2013,72(6):1011-1017.
[24] Schiefermueller J,Alaour B,Calver A,et al.Lesson of the month 1:beware the atypical presentation:eosinophilic granulomatosis with polyangiitis presenting as acute coronary syndrome[J].Clin Med (Lond),2017,17(2):180-182.
[25] Benallegue N,Lozach P,Belizna C,et al.Acute coronary vasospasm in a patient with eosinophilic granulomatosis with polyangiitis following NSAID administration:A case report[J].Medicine (Baltimore),2016,95(47):e5259.
[26] Bitar AY,Thompson CD,Tan CW,et al.Coronary artery vasospasm and cardiogenic shock as the initial presentation for eosinophilic granulomatosis with polyangiitis[J].J Cardiol Cases,2016,13(4):105-108.
[27] McGeoch L,Carette S,Cuthbertson D,et al.Cardiac involvement in granulomatosis with polyangiitis[J].J Rheumatol,2015,42(7):1209-1212.
[28] Grygiel-Gorniak B,Limphaibool N,Perkowska K,et al.Clinical manifestations of granulomatosis with polyangiitis:key considerations and major features[J].Postgrad Med,2018,130(7):581-596.
[29] Avina-Zubieta JA,Mai A,Amiri N,et al.Risk of myocardial infarction and stroke in patients with granulomatosis with polyangiitis (wegener’s):a population-based study[J].Arthritis Rheumatol,2016,68(11):2752-2759.
[30] Raghunathan V,Pelcovits A,Gutman D,et al.Cardiogenic shock from coronary vasculitis in granulomatosis with polyangiitis[J].BMJ Case Rep,2017,2017:bcr2017220233.
[31] Arenja N,Zimmerli L,Urbaniak P,et al.Acute anterior myocardial infarction after rituximab[J].Dtsch Med Wochenschr,2016,141(7):500-503.
[32] Desbois AC,Wechsler B,Cluzel P,et al.Cardiovascular involvement in Behcet’s disease[J].Rev Med Interne,2014,35(2):103-111.
[33] Kechida M,Salah S,Kahloun R,et al.Cardiac and vascular complications of Behcet disease in the Tunisian context:clinical characteristics and predictive factors[J].Adv Rheumatol,2018,58(1):32.
[34] Zhou J,Shi J,Liu J,et al.The clinical features,risk factors,and outcome of aneurysmal lesions in behcet’s disease[J].J Immunol Res,2019,2019:9198506.
[35] Chen H,Zhang Y,Li C,et al.Coronary involvement in patients with Behcet’s disease[J].Clin Rheumatol,2019,38(10):2835-2841.
[36] Siegrist PT,Sumitsuji S,Osuga K,et al.Endovascular coil embolization of Behcet disease-related giant aneurysm of the right coronary artery after failure of surgical suture[J].JACC Cardiovasc Interv,2013,6(6):e31-e32.
[37] Honda S,Hirano F,Mouri M,et al.Aneurysm formation after stent grafting in vascular Behcet’s disease[J].Arthritis Rheumatol,2018,70(2):322.
[38] Briguori C,Sarais C,Sivieri G,et al.Polytetrafluoroethylene-covered stent and coronary artery aneurysms[J].Catheter Cardiovasc Interv,2002,55(3):326-330.
[39] Sismanoglu M,Omeroglu SN,Mansuroglu D,et al.Coronary artery disease and coronary artery bypass grafting in Behcet’s disease[J].J Card Surg,2005,20(2):160-163.
[40] Vural U,Kizilay M,Aglar AA.Coronary Involvement in Behcet’s Disease:what are its Risks and Prognosis? (Rare Cases and Literature Review)[J].Braz J Cardiovasc Surg,2020,34(6):749-758.
相似文献/References:
[1]鲁鹏,综述,蔡琳,等.冠状动脉钙化的研究新进展[J].心血管病学进展,2016,(2):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
LU Peng,CAI Lin,HUANG Wei.New Progress of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2016,(8):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
[2]郑剑峰 邱洪.冠状动脉钙化研究进展[J].心血管病学进展,2020,(4):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
ZHENG JianFengQIU Hong.Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2020,(8):338.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
[3]田婷 罗俊一 杨毅宁.一种罕见的冠状动脉异常——编织样冠状动脉[J].心血管病学进展,2020,(9):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
TIAN Ting,LUO Junyi,YANG Yining.An Extremely Rare Anomaly of Coronary Artery[J].Advances in Cardiovascular Diseases,2020,(8):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
[4]白梦雪 赵慧强.低分子右旋糖酐光学相干断层成像技术在冠状动脉疾病中的应用进展[J].心血管病学进展,2022,(2):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
BAI MengxueZHAO Huiqiang.Application of Low Molecular Dextran Optical Coherence Tomography?n Coronary Arteries Disease[J].Advances in Cardiovascular Diseases,2022,(8):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
[5]陈璐 王国宏 郭彩霞.冠状动脉CT血管成像对冠心病预后预测价值及治疗策略指导意义[J].心血管病学进展,2022,(2):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
CHEN Lu,WANG Guohong,GUO Caixia.The Value of Coronary CT Angiography In Predicting the Prognosis and Treatment Strategies of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(8):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
[6]李俊鹏 刘建 刘娜 杨欣荣 高婷 赵正凯.“三低”技术在CT体部血管一站式成像的应用价值[J].心血管病学进展,2022,(7):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
LI Junpeng,LIU Jian,LIU Na,et al.Application of Three Lows Technology in One-Stop Imaging of CT Body Vessels[J].Advances in Cardiovascular Diseases,2022,(8):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[7]李依珂 高艳香 李青 郭紫玉 郑金刚.冠状动脉微循环侵入性检测方法研究进展[J].心血管病学进展,2023,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.008]
LI Yike,GAO Yanxiang,LI Qing,et al.Invasive Assessment of Coronary Microcirculation[J].Advances in Cardiovascular Diseases,2023,(8):30.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.008]
[8]李明 张慧平.急性ST段抬高心肌梗死患者直接经皮冠状动脉介入治疗后微血管功能障碍再认识[J].心血管病学进展,2023,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
LI Ming,ZHANG Huiping.Coronary Microvascular Dysfunction in Patients with Acute ST Segment?levation Myocardial Infarction After Primary Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2023,(8):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
[9]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(8):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
[10]张威 段高羊 郭瑶 唐明生 吴沣芝 蒋丰智.川崎病急性期中性粒细胞胞外诱捕网与血管损伤的相关研究[J].心血管病学进展,2024,(11):1046.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.018]
ZHANG Wei,DUAN Gaoyang,GUO Yao,et al.A Preliminary Study of the Involvement of Neutrophil Extracellular Traps on Vascular Injury in the Acute Phase of Kawasaki Disease[J].Advances in Cardiovascular Diseases,2024,(8):1046.[doi:10.16806/j.cnki.issn.1004-3934.2024.11.018]